Intravenous administration of infectivity enhanced conditionally replicative adenovirus shows augmented antitumor effect in orthotopic pancreatic cancer model

被引：0
|
作者：
Ramirez, PJ
Davydova, J
Curiel, DT
Vickers, SM
Yamamoto, M
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 36 条
  • [21] Enhanced antitumor effect of combination intravesical BCG plus Docetaxel therapy in an orthotopic bladder cancer model
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Iida, Masahiro
    Matsushima, Masashi
    Yanaihara, Hiroshi
    Nakahira, Yoko
    Ueno, Munehisa
    Asakura, Hirotaka
    CANCER RESEARCH, 2011, 71
  • [22] ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL BCG PLUS MMC THERAPY IN AN ORTHOTOPIC MURINE BLADDER CANCER MODEL
    Horinaga, Minoru
    Matsushima, Masashi
    Fukuyama, Ryuichi
    Yanaihara, Hitoshi
    Iida, Masahiro
    Nakahira, Yoko
    Asakura, Hirotaka
    JOURNAL OF UROLOGY, 2010, 183 (04): : E445 - E445
  • [23] ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL GEMICITABINE THERAPY PLUS BCG IN AN ORTHOTOPIC MURINE BLADDER CANCER MODEL
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Iida, Masahiro
    Yanaihara, Hitoshi
    Nakahira, Yoko
    Nonaka, Syoichi
    Deguchi, Nobuhiro
    JOURNAL OF UROLOGY, 2009, 181 (04): : 408 - 408
  • [24] Enhanced antitumor effect of coincident combination intravesical MMC plus BCG therapy in an orthotopic bladder cancer model
    Horinaga, Minoru
    Fukuyama, Ryuichi
    Matsushima, Masashi
    Yanaihara, Hitoshi
    Lida, Masahiro
    Nakahira, Yoko
    Asakura, Hirotaka
    CANCER RESEARCH, 2010, 70
  • [25] A Fiber and Hexon-Modified Infectivity-Selective Oncolytic Adenovirus Escapes Liver Sequestration After Systemic Administration in a Pancreatic Cancer Model
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Huang, Jing Li
    Jacobsen, Kari
    Hajeri, Praveensingh
    Yoshida, Hideki
    Davydova, Julia
    Yamamoto, Masato
    MOLECULAR THERAPY, 2017, 25 (05) : 265 - 265
  • [26] A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
    Kim, Kenneth H.
    Dmitriev, Igor P.
    Saddekni, Souheil
    Kashentseva, Elena A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Bae, Sejong
    Singh, Karan P.
    Siegal, Gene P.
    Curiel, David T.
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 518 - 524
  • [27] Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
    Estanislao Nistal-Villan
    Maria Bunuales
    Joanna Poutou
    Manuela Gonzalez-Aparicio
    Carlos Bravo-Perez
    Jose I. Quetglas
    Beatriz Carte
    Gloria Gonzalez-Aseguinolaza
    Jesus Prieto
    Esther Larrea
    Ruben Hernandez-Alcoceba
    Molecular Cancer, 14
  • [28] Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
    Nistal-Villan, Estanislao
    Bunuales, Maria
    Poutou, Joanna
    Gonzalez-Aparicio, Manuela
    Bravo-Perez, Carlos
    Quetglas, Jose I.
    Carte, Beatriz
    Gonzalez-Aseguinolaza, Gloria
    Prieto, Jesus
    Larrea, Esther
    Hernandez-Alcoceba, Ruben
    MOLECULAR CANCER, 2015, 14
  • [29] Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model
    Na, Youjin
    Choi, Joung-Woo
    Kasala, Dayananda
    Hong, JinWoo
    Oh, Eonju
    Li, Yan
    Jung, Soo-Jung
    Kim, Sung Wan
    Yun, Chae-Ok
    JOURNAL OF CONTROLLED RELEASE, 2015, 220 : 766 - 782
  • [30] Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer
    Wang, Qiuman
    Ma, Xinyue
    Wu, Huan
    Zhao, Chen
    Chen, Jingying
    Li, Rongrong
    Yan, Shi
    Li, Yingwei
    Zhang, Qing
    Song, Kun
    Yuan, Cunzhong
    Kong, Beihua
    ONCOIMMUNOLOGY, 2022, 11 (01):
1234